Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(MDRX)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
19.06 USD   +0.85%
11/30Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Practice Management
PR
11/22Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Point of Care Marketing Association
BU
11/18JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintains Underweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Allscripts to Release First-Quarter 2022 Financial Results May 5

04/21/2022 | 08:17am EST

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursday, May 5, 2022. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day.

First-Quarter 2022 Financial Results Call Details

The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on Thursday, May 5, 2022. The announcement will also be available at Allscripts investor relations website.

To listen to the conference call, participants may log onto the Allscripts Investor Relations website. Participants also may access the conference call by dialing 877-269-7756 or 201-689-7817 and requesting Conference ID # 13728930.

A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts investor relations website or by calling (877) 660-6853 or (201) 612-7415 - Conference ID # 13728930.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.


© Business Wire 2022
All news about ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
11/30Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Prac..
PR
11/22Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Poin..
BU
11/18JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maint..
MT
11/14Insider Sell: Allscripts Healthcare Solutions
MT
11/10Allscripts - Veradigm EHR Achieves 2015 ONC Health IT Update Certification
AQ
11/09Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Pri..
MT
11/09Veradigm EHR Achieves 2015 ONC Health IT Update Certification
BU
11/07ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Management's Discussion and Analysis of Financia..
AQ
11/07Tranche Update on Allscripts Healthcare Solutions, Inc.'s Equity Buyback Plan announced..
CI
11/07Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Mai..
MT
More news
Analyst Recommendations on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
More recommendations
Financials (USD)
Sales 2022 615 M - -
Net income 2022 1,69 M - -
Net cash 2022 300 M - -
P/E ratio 2022 -318x
Yield 2022 -
Capitalization 2 082 M 2 082 M -
EV / Sales 2022 2,90x
EV / Sales 2023 2,74x
Nbr of Employees 8 000
Free-Float 38,1%
Chart ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Duration : Period :
Allscripts Healthcare Solutions, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,06 $
Average target price 22,00 $
Spread / Average Target 15,4%
EPS Revisions
Managers and Directors
Richard J. Poulton Chief Executive Officer & Director
Thomas Langan President
Leah Jones Vice President-Finance & Sales Support
Joseph R. Rostock Chief Technology Officer & SVP-Product Engineering
Tejal Vakharia Chief Compliance Counsel & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.3.31%2 082
VEEVA SYSTEMS INC.-31.54%27 159
PRO MEDICUS LIMITED-2.35%4 319
SECTRA AB (PUBL)-12.29%3 258
EVOLENT HEALTH, INC.3.29%2 848
OMNICELL, INC.-71.82%2 270